Andrew Levine, Ph.D., ABPP, QME

Andrew Levine, Ph.D., ABPP, QME

North Coast Neuropsychology
Offices in Long Beach, Cerritos, and Arcata
Arcata, CA 95521
Office: 562-477-5963
Fax: 510-280-2993
Introduction

Dr. Levine is a clinical neuropsychologist who is board-certified through the American Board of Professional Psychology. He has been involved in clinical and medico-legal practice and consultation since 2005. He has been a Qualified Medical Examiner for the California Department of Workers' Compensation since 2018. Dr. Levine is a scientist/clinician with an appointment as Adjunct Professor with the Department of Neurology at the David Geffen School of Medicine at UCLA. He has developed a successful NIH-funded, multidisciplinary research program at UCLA focused on psychometrics, neurodegenerative disease (e.g., Alzheimer's Disease and Frontotemporal Dementia), and the neurocognitive effects of HIV infection. He has published on the neuropsychology of COVID-19.


Areas of Expertise
  • Alcohol Abuse
  • Brain Injury
  • Competency
  • Drug Abuse
  • Malingering
  • Neurodevelopmental Disorder/Disability
  • Neuropsychology
  • Post Traumatic Stress Disorder
  • Psychology
  • Testamentary Capacity

Expert Background
Q: Please list your professional accreditations, degrees, licenses, and certificates granted:
A: Clinical Psychologist License (California) - PSY20320
American Board of Professional Psychology - Clinical Neuropsychology – 6805
Qualified Medical Evaluator - California Department of Workers’ Compensation
Human Intervention Motivation Study (HIMS) - Aerospace Neuropsychology
Q: Please list your affiliations or memberships in any professional and/or industry organizations:
A: Department of Neurology - UCLA David Geffen School of Medicine
Q: Please list any teaching or speaking experience you have had, including subject matter:
A: CLASSES
Neurophilosophy (Course – undergraduate)
California State University – Dominguez Hills

Neurophilosophy (Course – undergraduate)
University of California, Los Angeles

Psychodiagnostic Assessment (Course – graduate)
Alliant International University

Psychological Assessment (Course - undergraduate)
Loyola Marymount University

Introduction to Psychological Testing (Course - grad and undergraduate)
California State University, Northridge

INVITED TALKS & PRESENTATIONS

Levine, A.J. Frontotemporal Lobar Degeneration and Related Syndromes. Presented at NIBBL seminar, Department of Neuropsychology, UCLA-Semel Institute for Neuroscience and Human Behavior. April 9, 2009

Levine, A.J. HIV-Associated Neurocognitive Disorders. Presented at Neurologic and Neuropsychiatric Syndromes Course, Department of Neuropsychology, UCLA-Semel Institute for Neuroscience and Human Behavior. June 11, 2009

Levine, A.J. The Genetics of HIV-Associated Neurocognitive Disorder. Presented at NIBBL seminar, Department of Neuropsychology, UCLA-Semel Institute for Neuroscience and Human Behavior. March 25, 2010

Levine, A.J. The Neuropsychology of Infectious Diseases. Presented at Neurologic and Neuropsychiatric Syndromes Course, Department of Neuropsychology, UCLA-Semel Institute for Neuroscience and Human Behavior. May 7, 2010

Levine, A.J. Genetic studies of HIV-associated neurocognitive disorders. Presented at the Multicenter AIDS Cohort Study Working Group Meeting, October 19, 2010

Levine, A.J. Genetic studies of NeuroAIDS in the NNTC. Presented at the National NeuroAIDS Tissue Consortium Scientific Leadership Group Meeting, October 28, 2010

Levine, A.J., Genetic risk factors for HIV-associated neurocognitive disorders. Presented at the 91st annual convention of the Western Psychological Association, April 28th, 2011

Levine, A.J. HIV-Related Neurobehavioral Aberrations. Invited talk for the Northern California Neuropsychological Forum, October 26th, 2011

Levine, A.J. Case presentation of HIV-associated neurocognitive disorder. Invited talk for the Northern California Neuropsychological Forum, March 21st, 2012

Levine, A.J. Longitudinal analysis of interactive effects of host genotype, stimulant use, and HIV status upon neurocognitive functioning. Presented at the 11th Symposium of the International Society on NeuroVirology, May 31, 2012

Levine, A.J. Genomic, Transcriptomic, and Epigenomic Studies in the Multicenter AIDS Cohort Study. Presented at the Annual MACS/WIHS Meeting, November 7, 2014

Levine, A.J. Neuropsychological manifestations of HIV-1 infection. Presented for the UCLA School of Epidemiology, May 27, 2016

Levine, A. Peripheral blood monocyte transcriptome at baseline implicates Wnt-signaling pathway in later neurocognitive change. Presented at the 14th meeting of the International Society on NeuroVirology, Toronto, Canada, October 25-28, 2016

Levine, A.J. HIV-associated neurocognitive disorders: fact or fiction? Presented for the UCLA School of Epidemiology, May 10, 2017

Levine, A.J., Suboptimal effort during neuropsychological testing in the MACS: causes, consequences, and solutions. Presented for the MACS Scientific Works In Progress series, November 1, 2017

Levine, A.J. HIV-associated neurocognitive disorders: fact or fiction? Presented for the UCLA School of Epidemiology, May 18, 2018

Levine, A.J. Bridging molecular genetics and neuropsychology in the study of NeuroHIV. Presented for the Veterans Administration Medical Center, Long Beach, April 17, 2019

Levine, A.J. HIV-associated neurocognitive disorders: fact from fiction. Presented for the UCLA School of Epidemiology, Epidemiology 227 - AIDS: A Major Public Health Challenge. April 19, 2019

Levine, A.J. HIV-associated neurocognitive disorders: fact from fiction. Presented for the UCLA School of Epidemiology, Epidemiology 227 - AIDS: A Major Public Health Challenge. May 8, 2020

Levine, A.J. NeuroCOVID: Current Understanding and Methods of Study through the lens of NeuroHIV. Presented for the Frank F. LeFever Annual NYNG Conference “From HIV to COVID-19: The Neuropsychology of Infectious Disease”. September 16, 2020
Q: Have any of your accreditations ever been investigated, suspended or removed? (if yes, explain)
A: No
Q: On how many occasions have you been retained as an expert?
A: 20
Q: For what area(s) of expertise have you been retained as an expert?
A: Neuropsychology, PTSD, TBI, COVID-19, Dementia
Q: In what percentage of your cases were you retained by the plaintiff?
A: 50
Q: In what percentage of your cases were you retained by the defendant?
A: 50
Q: On how many occasions have you had your deposition taken?
A: 15
Q: When was the last time you had your deposition taken?
A: October 2023
Q: On how many occasions have you testified as an expert in court or before an arbitrator?
A: 4
Q: For how many years have you worked with the legal industry as an expert?
A: 8
Q: What services do you offer? (E.g.: consulting, testing, reports, site inspections etc.)
A: Consultation, testing, reviewing records/reports
Q: What is your hourly rate to consult with an attorney?
A: $500
Q: What is your hourly rate to review documents?
A: $500
Q: What is your hourly rate to provide deposition testimony?
A: $500
Q: What is your hourly rate to provide testimony at trial?
A: Day and half-day rates
Q: Please list any fees other than those stated above (E.g.: travel expenses, copy fees, etc.)
A: Please contact for full fee schedule.


References

Available Upon Request